Shop

Ryzodeg 30/70 Injection (Insulin Degludec & Insulin Aspart) is a premixed insulin product combining 70% long-acting Insulin Degludec with 30% rapid-acting Insulin Aspart to provide both basal and mealtime coverage in one convenient administration. This fixed-ratio formulation offers flexibility and effectiveness in blood sugar control.

Each dose delivers a precise blend of ultra‑long‑acting and fast-acting insulin to help manage pre-meal and fasting glucose levels. Patients benefit from stable glucose control throughout the day with fewer injections and greater simplicity in therapy management.

Ryzodeg 30/70 comes in a user-friendly, pre-filled pen compatible with standard insulin pen needles. Healthcare providers usually recommend it for adults with type 1 and type 2 diabetes, particularly for patients looking to simplify their basal-bolus regimen.

To use, inject subcutaneously once or twice daily with meals, as prescribed by your doctor. Rotate injection sites between the abdomen, thigh, or upper arm to prevent lipodystrophy. The pen ensures accurate doses and simplifies administration.

Store unused pens in a refrigerator at 2 °C to 8 °C. Once in use, you may keep the pen at room temperature (below 30 °C) and discard it after 28 days, even if it still contains insulin.